BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 857207)

  • 1. Microglandular hyperplasia in vaginal adenosis associated with oral contraceptives and prenatal diethylstilbestrol exposure.
    Robboy SJ; Welch WR
    Obstet Gynecol; 1977 Apr; 49(4):430-4. PubMed ID: 857207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinicopathologic study of vagina and cervix in DES-exposed progeny.
    Zerner J; Fu YS; Taxiarchis LN; Reagan JW; Richart RM
    Diagn Gynecol Obstet; 1980; 2(4):245-56. PubMed ID: 7215109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical diagnosis of vaginal adenosis.
    Stafl A; Mattingly RF; Foley DV; Fetherston WC
    Obstet Gynecol; 1974 Jan; 43(1):118-28. PubMed ID: 4808952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Adenosis.
    Kurman RJ; Norris HJ
    Obstet Gynecol; 1975 Sep; 46(3):373-4. PubMed ID: 1161246
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytology of 575 young women with prenatal exposure to diethylstilbestrol.
    Robboy SJ; Friedlander LM; Welch WR; Keh PC; Taft PD; Barnes AB; Scully RE; Herbst AL
    Obstet Gynecol; 1976 Nov; 48(5):511-5. PubMed ID: 980279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of vaginal adenosis in women exposed to diethylstilbestrol in utero.
    Ng AB; Reagan JW; Nadji M; Greening S
    J Reprod Med; 1977 Jan; 18(1):1-13. PubMed ID: 833795
    [No Abstract]   [Full Text] [Related]  

  • 8. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.
    Kurman RJ
    West J Med; 1979 Dec; 131(6):526-32. PubMed ID: 545869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
    Robboy SJ; Scully RE; Welch WR; Herbst AL
    Arch Pathol Lab Med; 1977 Jan; 101(1):1-5. PubMed ID: 576195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.
    Scully RE; Robboy SJ; Herbst AL
    Ann Clin Lab Sci; 1974; 4(4):222-33. PubMed ID: 4460850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition of benign vaginal adenosis to clear cell carcinoma.
    Ghosh TK; Cera PJ
    Obstet Gynecol; 1983 Jan; 61(1):126-30. PubMed ID: 6823342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of microglandular hyperplasia of the cervix uteri.
    Wilkinson E; Dufour DR
    Obstet Gynecol; 1976 Feb; 47(2):189-95. PubMed ID: 1250541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal adenosis. Correlation of colposcopic and pathologic findings.
    Burke L; Antonioli D; Knapp RC; Friedman EA
    Obstet Gynecol; 1974 Aug; 44(2):257-64. PubMed ID: 4422246
    [No Abstract]   [Full Text] [Related]  

  • 17. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
    Sherman AI; Goldrath M; Berlin A; Vakhariya V; Banooni F; Michaels W; Goodman P; Brown S
    Obstet Gynecol; 1974 Oct; 44(4):531-45. PubMed ID: 4412373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic findings in stilbestrol exposed females with emphasis on detection of vaginal adenosis.
    Hart WR; Zaharov I; Kaplan BJ; Townsend DE; Aldrich JO; Henderson BE; Roy M; Benton B
    Acta Cytol; 1976; 20(1):7-14. PubMed ID: 1063525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
    Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
    Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglandular hyperplasia of the uterine cervix.
    Chumas JC; Nelson B; Mann WJ; Chalas E; Kaplan CG
    Obstet Gynecol; 1985 Sep; 66(3):406-9. PubMed ID: 4022499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.